Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > weekend update & week ahead
View:
Post by canadafan on Aug 18, 2024 4:23pm

weekend update & week ahead

Hello all
As I mentioned previously, I have a lot going on right now.
Saying thst, I bought a few more Onc shares last week.
updste?
Nothing new for those in the know.
The pancreatic cancer phase 3 / registration trial still expects to start up , early 2025.
The very very long awaited O.S. Results for the MBc phase 2 bracelet trial, due reportedly before end if this year.
Presently the do not have a named partner/ colaborators for the next steps with MBc.
They did indicate positive results will increase their negotiation strength. While that is an obvious statement, worth stating.
Considering it is a near copy if the previous phase 2 trial & indications of strong results, almost an assumed conclusion.
Add- on since then, they had a meeting with FDA to further refine the process, including accepting biomarkers & other details....the strength going into phase 3 should be a very positive trinket for a potential partner.
They also started enrolment into an additional arm , for the Gobblet trial with Roche.
Where 2 yrs ago, Onc was a one phase 3 potential, now 2 , with a possible 3rd.
The SP refects none of those realities, therfore imho way beyond silly.
Could everything fall flat? Possible. Not likeky.
CGAR the lead colaborator with panc cancer & preceeeded by PanCan , precision promise detailed D.D. , donated $5million...and are in full support of the upcoming panc cancer opportunity.
Everyone, have a great week.
Comment by Quentin30 on Aug 20, 2024 2:47pm
"Could everything fall flat? Possible. Not likeky." some folk just don't know when to throw in the towel on a company...?  even Matt couldn't take lying to investors anymore... yah, Aware-1, all that Roche needed to pull the trigger on a deal eh Matt... P{recision Promise arent the only ones who've given ONCY 5 milion... their partner Adlai Nortye also gave ONCY same ...more  
Comment by Azzak34 on Aug 20, 2024 2:58pm
Haha what a childish little buffoon. Every call yoube made on here is in the dirt.  I asked you before you before to share your wisdom.  What should we buy, for how much and when do we sell. You keep avoiding the opportunity to prove yourself. 
Comment by venture009 on Aug 21, 2024 12:37am
Azzak, Quentin makes a good point regarding AN paying for reo and now not even referencing it as part of their pipeline.  Why is that?
Comment by Azzak34 on Aug 21, 2024 4:44am
I have no idea, but neither does he. What would be the point in guessing with no information.  We're due the Bracelet update any day. Have a look around at what's happening in tech and biotech.....there are closures, layoffs, bought deals and stock splits everywhere. We are surviving at a time when others are floundering.  If Bracelet doesn't provide good data then it' ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities